A 35-year-old woman (G4P3L3, 1 abortion) attends the outpatient clinic requesting permanent contraception. She has completed her family and has no medical contraindications. On examination, she is normotensive, non-obese (BMI 23 kg/m²), and has no pelvic pathology. She is undecided between tubal ligation and copper intrauterine device (IUCD). What is the most appropriate next step in management?

Explanation

## Clinical Decision-Making Framework The patient is seeking permanent contraception with no absolute contraindications. The key principle is **informed autonomous choice** based on comprehensive counselling of all suitable options. ## Comparative Analysis: Tubal Ligation vs. Copper IUCD **Key Point:** While tubal ligation is permanent and highly effective, the copper IUCD offers comparable efficacy with the advantage of reversibility — a critical distinction that must be presented to the patient. | Feature | Tubal Ligation | Copper IUCD (10-year) | |---------|---|---| | **Efficacy (Pearl Index)** | 0.1–0.5 per 100 woman-years | 0.2–0.8 per 100 woman-years | | **Reversibility** | Irreversible (reversal possible but unreliable) | Fully reversible; fertility restored immediately | | **Invasiveness** | Surgical procedure; general/regional anaesthesia | Outpatient insertion; minimal discomfort | | **Failure Rate** | Lowest among reversible methods | Comparable to tubal ligation | | **Regret Rate** | 5–20% (higher in younger women) | Lower (reversibility reduces regret) | | **Menstrual Changes** | None | May increase flow/dysmenorrhoea (5–10%) | | **Cost** | Higher (surgical) | Lower (outpatient procedure) | | **Complications** | Bowel/vascular injury, anaesthetic risk | Expulsion (2–5%), perforation (rare) | **High-Yield:** The copper IUCD is classified as a **long-acting reversible contraceptive (LARC)** with efficacy comparable to permanent methods but with the critical advantage of reversibility. WHO and NFHS guidelines recommend LARC as first-line for women desiring long-term contraception. ## Ethical & Counselling Principles **Clinical Pearl:** Informed consent in contraceptive counselling requires: 1. **Explanation of all suitable options** (not just one) 2. **Comparative information** on efficacy, reversibility, risks, and benefits 3. **Respect for autonomous choice** — the patient decides, not the provider 4. **Documentation** of counselling and the patient's choice **Key Point:** Recommending only tubal ligation or defaulting to IUCD without counselling violates the principle of informed autonomous choice and may constitute coercion, which is ethically and legally problematic in India. ## Why This Approach Is Optimal **Mnemonic:** **CHOICE** = **C**ounselling on **H**ormonal and **O**ther **I**ntrauterine **C**ontraceptiv**E** options. At age 35 with completed family, the patient is an ideal candidate for both methods. However, the reversibility of the copper IUCD is a game-changer: even though she states her family is complete, life circumstances change (remarriage, loss of a child, change in partner preference). The copper IUCD provides a 10-year window of highly effective contraception with the option to reverse if needed. ## Guideline Alignment [cite:Park 26e Ch 9 — Family Planning], [cite:NFHS-5 Contraceptive Use], [cite:WHO Contraceptive Sterilization Guidelines] Indian guidelines emphasize **informed choice** and recommend LARC methods (including copper IUCD) as first-line for women desiring long-term contraception, with permanent methods reserved for those who explicitly choose irreversibility after full counselling.